StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

ResMed's operating cash flow for the twelve months ending Sep 30, 2026 was $1.77B, down 6.0% year over year. For fiscal 2026 it was $1.81B, up 3.1% from the year before. Over ten years it grew 12.7% a year on average. The highest annual figure on record is $1.81B in fiscal 2026.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.81B+3.1%
FY2025Jun 30, 2025$1.75B+25.0%
FY2024Jun 30, 2024$1.40B+102.1%
FY2023Jun 30, 2023$693.30M+97.4%
FY2022Jun 30, 2022$351.15M-52.3%
FY2021Jun 30, 2021$736.72M-8.2%
FY2020Jun 30, 2020$802.26M+74.8%
FY2019Jun 30, 2019$459.05M-9.1%
FY2018Jun 30, 2018$505.03M+22.0%
FY2017Jun 30, 2017$414.05M-24.4%
FY2016Jun 30, 2016$547.93M+43.0%
FY2015Jun 30, 2015$383.18M-2.1%
FY2014Jun 30, 2014$391.27M-2.9%
FY2013Jun 30, 2013$402.82M+5.1%
FY2012Jun 30, 2012$383.16M+35.3%
FY2011Jun 30, 2011$283.19M+50.5%
FY2010Jun 30, 2010$188.21M-21.2%
FY2009Jun 30, 2009$238.88M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$422.42M-7.6%
Q4 FY2026CQ2 2026Jun 30, 2026$454.63M-15.6%
Q3 FY2026CQ1 2026Mar 31, 2026$554.13M-4.2%
Q2 FY2026CQ4 2025Dec 31, 2025$339.75M+10.1%
Q1 FY2026CQ3 2025Sep 30, 2025$457.32M+40.5%
Q4 FY2025CQ2 2025Jun 30, 2025$538.77M+22.4%
Q3 FY2025CQ1 2025Mar 31, 2025$578.66M+43.9%
Q2 FY2025CQ4 2024Dec 31, 2024$308.62M+13.1%
Q1 FY2025CQ3 2024Sep 30, 2024$325.54M+13.7%
Q4 FY2024CQ2 2024Jun 30, 2024$440.11M+85.4%
Q3 FY2024CQ1 2024Mar 31, 2024$402.03M+42.3%
Q2 FY2024CQ4 2023Dec 31, 2023$272.83M+112.1%
Q1 FY2024CQ3 2023Sep 30, 2023$286.28M+541.0%
Q4 FY2023CQ2 2023Jun 30, 2023$237.44M+198.7%
Q3 FY2023CQ1 2023Mar 31, 2023$282.57M+140.6%
Q2 FY2023CQ4 2022Dec 31, 2022$128.64M-41.5%
Q1 FY2023CQ3 2022Sep 30, 2022$44.66M–
Q4 FY2022CQ2 2022Jun 30, 2022$79.49M-64.9%
Q3 FY2022CQ1 2022Mar 31, 2022$117.44M-40.2%
Q2 FY2022CQ4 2021Dec 31, 2021$219.88M+29.4%
Q1 FY2022CQ3 2021Sep 30, 2021-$65.66M-145.6%
Q4 FY2021CQ2 2021Jun 30, 2021$226.53M-31.4%
Q3 FY2021CQ1 2021Mar 31, 2021$196.28M-18.1%
Q2 FY2021CQ4 2020Dec 31, 2020$169.92M+143.0%
Q1 FY2021CQ3 2020Sep 30, 2020$144.00M-11.3%
Q4 FY2020CQ2 2020Jun 30, 2020$330.27M+132.9%
Q3 FY2020CQ1 2020Mar 31, 2020$239.70M+71.6%
Q2 FY2020CQ4 2019Dec 31, 2019$69.93M-46.0%
Q1 FY2020CQ3 2019Sep 30, 2019$162.36M+237.4%
Q4 FY2019CQ2 2019Jun 30, 2019$141.82M+9.6%
Q3 FY2019CQ1 2019Mar 31, 2019$139.65M-6.3%
Q2 FY2019CQ4 2018Dec 31, 2018$129.47M-2.3%
Q1 FY2019CQ3 2018Sep 30, 2018$48.12M-48.8%
Q4 FY2018CQ2 2018Jun 30, 2018$129.42M-7.8%
Q3 FY2018CQ1 2018Mar 31, 2018$149.08M+120.5%
Q2 FY2018CQ4 2017Dec 31, 2017$132.55M+10.6%
Q1 FY2018CQ3 2017Sep 30, 2017$93.98M–
Q4 FY2017CQ2 2017Jun 30, 2017$140.31M–
Q3 FY2017CQ1 2017Mar 31, 2017$67.60M–
Q2 FY2017CQ4 2016Dec 31, 2016$119.90M–

More ResMed figures

See a number that looks wrong?